Logo image of TUB.BR

FINANCIERE DE TUBIZE (TUB.BR) Stock Fundamental Analysis

Europe - EBR:TUB - BE0003823409 - Common Stock

199.6 EUR
-0.2 (-0.1%)
Last: 11/19/2025, 7:00:00 PM
Fundamental Rating

3

TUB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. No worries on liquidiy or solvency for TUB as it has an excellent financial health rating, but there are worries on the profitability. TUB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

TUB had positive earnings in the past year.
In the past year TUB has reported a negative cash flow from operations.
In the past 5 years TUB has always been profitable.
TUB had a negative operating cash flow in each of the past 5 years.
TUB.BR Yearly Net Income VS EBIT VS OCF VS FCFTUB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

1.2 Ratios

TUB has a Return On Assets of 4.79%. This is comparable to the rest of the industry: TUB outperforms 48.15% of its industry peers.
Looking at the Return On Equity, with a value of 4.79%, TUB is in line with its industry, outperforming 40.74% of the companies in the same industry.
Industry RankSector Rank
ROA 4.79%
ROE 4.79%
ROIC N/A
ROA(3y)4.63%
ROA(5y)5.57%
ROE(3y)4.88%
ROE(5y)5.78%
ROIC(3y)N/A
ROIC(5y)N/A
TUB.BR Yearly ROA, ROE, ROICTUB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

TUB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TUB.BR Yearly Profit, Operating, Gross MarginsTUB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

More info and screens

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, TUB has about the same amount of shares outstanding.
Compared to 5 years ago, TUB has more shares outstanding
The debt/assets ratio for TUB has been reduced compared to a year ago.
TUB.BR Yearly Shares OutstandingTUB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TUB.BR Yearly Total Debt VS Total AssetsTUB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

TUB has an Altman-Z score of 14540.35. This indicates that TUB is financially healthy and has little risk of bankruptcy at the moment.
TUB has a Altman-Z score of 14540.35. This is amongst the best in the industry. TUB outperforms 100.00% of its industry peers.
TUB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 14540.35
ROIC/WACCN/A
WACCN/A
TUB.BR Yearly LT Debt VS Equity VS FCFTUB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

TUB has a Current Ratio of 10.33. This indicates that TUB is financially healthy and has no problem in meeting its short term obligations.
TUB has a Current ratio of 10.33. This is amongst the best in the industry. TUB outperforms 100.00% of its industry peers.
TUB has a Quick Ratio of 10.33. This indicates that TUB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 10.33, TUB belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.33
Quick Ratio 10.33
TUB.BR Yearly Current Assets VS Current LiabilitesTUB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

TUB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.02%.
Measured over the past years, TUB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.68% on average per year.
EPS 1Y (TTM)3.02%
EPS 3Y2.13%
EPS 5Y-20.68%
EPS Q2Q%2.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TUB.BR Yearly Revenue VS EstimatesTUB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 50M 100M 150M 200M 250M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 95.96, which means the current valuation is very expensive for TUB.
64.81% of the companies in the same industry are cheaper than TUB, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 25.46. TUB is valued rather expensively when compared to this.
Industry RankSector Rank
PE 95.96
Fwd PE N/A
TUB.BR Price Earnings VS Forward Price EarningsTUB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TUB.BR Per share dataTUB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TUB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FINANCIERE DE TUBIZE

EBR:TUB (11/19/2025, 7:00:00 PM)

199.6

-0.2 (-0.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-02 2025-08-02
Earnings (Next)03-21 2026-03-21
Inst Owners4.2%
Inst Owner ChangeN/A
Ins Owners33.27%
Ins Owner ChangeN/A
Market Cap8.88B
Revenue(TTM)N/A
Net Income(TTM)92.74M
Analysts76.67
Price Target235.11 (17.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.97
Dividend Growth(5Y)7.33%
DP0.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)23.76%
PT rev (3m)26.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 95.96
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.59
P/tB 4.59
EV/EBITDA N/A
EPS(TTM)2.08
EY1.04%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS43.5
TBVpS43.5
PEG (NY)N/A
PEG (5Y)N/A
Graham Number45.12
Profitability
Industry RankSector Rank
ROA 4.79%
ROE 4.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)4.63%
ROA(5y)5.57%
ROE(3y)4.88%
ROE(5y)5.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.33
Quick Ratio 10.33
Altman-Z 14540.35
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.02%
EPS 3Y2.13%
EPS 5Y-20.68%
EPS Q2Q%2.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.98%
OCF growth 3YN/A
OCF growth 5YN/A

FINANCIERE DE TUBIZE / TUB.BR FAQ

What is the fundamental rating for TUB stock?

ChartMill assigns a fundamental rating of 3 / 10 to TUB.BR.


What is the valuation status for TUB stock?

ChartMill assigns a valuation rating of 0 / 10 to FINANCIERE DE TUBIZE (TUB.BR). This can be considered as Overvalued.


How profitable is FINANCIERE DE TUBIZE (TUB.BR) stock?

FINANCIERE DE TUBIZE (TUB.BR) has a profitability rating of 2 / 10.


What is the valuation of FINANCIERE DE TUBIZE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FINANCIERE DE TUBIZE (TUB.BR) is 95.96 and the Price/Book (PB) ratio is 4.59.


Can you provide the financial health for TUB stock?

The financial health rating of FINANCIERE DE TUBIZE (TUB.BR) is 9 / 10.